Buy Piramal Pharma; target of Rs 171: Asit C Mehta
Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.
Source: moneycontrol.com
Complex Hospital Generic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Complex Hospital Generic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Complex Hospital Generic Today - Breaking & Trending Today
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M)...
Source: prnewswire.com
Piramal Pharma Ltd: Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
MUMBAI, India, Feb. 8, 2023 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M) ended
Source: finanznachrichten.de
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M)...
Source: prnewswire.com